Xing Q B, Chen S, Chen B, Li H F, Chen L L
Asthmatic Children Prevention and Specific Immunotherapy Center, Peoples' Hospital of Hainan Province, Haikou, 570203, China.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Feb 5;31(3):204-208. doi: 10.13201/j.issn.1001-1781.2017.03.009.
To evaluate the efficacy of SLIT with Dermatophagoides farina drops in monosensitized and polysensitized children with allergic rhinitis and asthma.This retrospective analysis chose 124 cases of allergic rhinitis and asthma with 3 years SLIT treatment. According to skin prick test,they were divided into two groups, monosensitized group (48 patients) and polysensitized group (76 patients). Before SLIT and after SLIT for 1 year, 2 year and 3 years, the TNSS, TRMS of rhinitis and DASS, NASS, TAMS, VAS, PEF, FEV1 of asthma were evaluated. The TNSS, TRMS, DASS, NASS, TAMS, VAS, PEF, FEV1 had continuously improved significantly after SLIT for 1 year, 2 year and 3 years in two groups as compared with baseline (< 0.05). As compared with after SLIT for 1 year, after SLIT for 2 year the TNSS, TRMS, TAMS, VAS of monosensitized group had obviously decrease (= 3.76, 5.57, 6.02, 5.62, < 0.05). As compared with after SLIT for 1 year, similarly, after SLIT for 2 year the TNSS, TRMS, TAMS, VAS of polysensitized group had obviously decrease (= 5.40, 7.16, 7.19, 7.87, < 0.05). Before SLIT, TRMS and TAMS of polysensitized group were significantly greater than the monosensitized group (=3.16, 2.74, < 0.05). After SLIT for 1 year, 2 years and 3 years, the all evaluation indicators of two groups were not statistically significant (> 0.05).Sublingual immunotherapy with Dermatophagoides farina drops in monosensitized and polysensitized children with allergic rhinitis and asthma had similar and significant therapeutic effect.
评估粉尘螨滴剂舌下免疫治疗对单致敏和多致敏变应性鼻炎合并哮喘儿童的疗效。本回顾性分析选取124例接受3年舌下免疫治疗的变应性鼻炎合并哮喘患儿。根据皮肤点刺试验,将其分为两组,单致敏组(48例)和多致敏组(76例)。在舌下免疫治疗前以及治疗1年、2年和3年后,评估鼻炎的TNSS、TRMS以及哮喘的DASS、NASS、TAMS、VAS、PEF、FEV1。与基线相比,两组在舌下免疫治疗1年、2年和3年后,TNSS、TRMS、DASS、NASS、TAMS、VAS、PEF、FEV1均持续显著改善(<0.05)。与舌下免疫治疗1年后相比,单致敏组在舌下免疫治疗2年后,TNSS、TRMS、TAMS、VAS明显降低(=3.76、5.57、6.02、5.62,<0.05)。同样,与舌下免疫治疗1年后相比,多致敏组在舌下免疫治疗2年后,TNSS、TRMS、TAMS、VAS明显降低(=5.40、7.16、7.19、7.87,<0.05)。舌下免疫治疗前,多致敏组的TRMS和TAMS显著高于单致敏组(=3.16、2.74,<0.05)。在舌下免疫治疗1年、2年和3年后,两组的所有评估指标均无统计学差异(>0.05)。粉尘螨滴剂舌下免疫治疗对单致敏和多致敏变应性鼻炎合并哮喘儿童具有相似且显著的治疗效果。